TOI
Oncology Institute, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$5.13
−19.72%Latest reported
- Last report date
- May 7, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.07
- Revenue actual
- $147.4M
- Revenue estimate
- $142.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +36.6%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $9.50
- PT range
- $9.00 – $10
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 7, 2026 | -$0.07 | -$0.02 | Beat 71.43% | $147.4M |
| Mar 12, 2026 | -$0.09 | -$0.01 | Beat 91.78% | $142.0M |
| Nov 13, 2025 | -$0.12 | -$0.14 | Miss -16.67% | $136.6M |
| Aug 13, 2025 | -$0.14 | -$0.14 | In line | $119.8M |
| May 14, 2025 | — | -$0.17 | — | $104.4M |
| Mar 24, 2025 | -$0.08 | -$0.14 | Miss -75.00% | $100.3M |
| Mar 9, 2023 | -$0.18 | -$0.16 | Beat 11.11% | $71.4M |
| Nov 9, 2022 | -$0.16 | -$0.17 | Miss -6.25% | $65.0M |
| Mar 10, 2022 | — | $0.26 | — | $52.3M |
| Aug 16, 2021 | — | $0.05 | — | $49.8M |
| May 28, 2021 | — | -$0.02 | — | $48.6M |
| Nov 13, 2020 | — | -$0.02 | — | $47.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 6, 2026